| scholarly article | Q13442814 |
| P50 | author | Takanori Kitamura | Q57070919 |
| Gael Sugano | Q63430525 | ||
| P2093 | author name string | Bin-Zhi Qian | |
| Daniel Soong | |||
| Jeffrey W Pollard | |||
| Jiufeng Li | |||
| Luca Cassetta | |||
| Roy Noy | |||
| Yu Kato | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins | Q24316481 | ||
| Tissue-resident macrophages | Q26991488 | ||
| Conditional deletion of the colony stimulating factor-1 receptor (c-fms proto-oncogene) in mice. | Q50647275 | ||
| Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. | Q52022061 | ||
| Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis | Q59052622 | ||
| Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma | Q71614098 | ||
| Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy | Q72105942 | ||
| Macrophage inflammatory protein-2 and KC induce chemokine production by mouse astrocytes | Q73084811 | ||
| Differential expression and regulation of macrophage inflammatory protein (MIP)-1alpha and MIP-2 genes by alveolar and peritoneal macrophages in LPS-hyporesponsive C3H/HeJ mice | Q73167767 | ||
| Macrophage inflammatory protein 1alpha enhances in a different manner adhesion of hematopoietic progenitor cells from bone marrow, cord blood, and mobilized peripheral blood | Q73180463 | ||
| Chemokines induce migrational responses in human breast carcinoma cell lines | Q73316679 | ||
| Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection | Q73453124 | ||
| Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages | Q73680305 | ||
| RANTES-induced chemokine cascade in dendritic cells | Q74244283 | ||
| Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction | Q75346669 | ||
| CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets | Q80566296 | ||
| MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4 | Q81652318 | ||
| Host-derived MCP-1 and MIP-1α regulate protective anti-tumor immunity to localized and metastatic B16 melanoma | Q82255516 | ||
| A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth | Q27345215 | ||
| Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor | Q28297700 | ||
| Monocyte chemoattractant protein-1/CC chemokine ligand 2 enhances apoptotic cell removal by macrophages through Rac1 activation | Q28593541 | ||
| Genes that mediate breast cancer metastasis to lung | Q29547479 | ||
| Microenvironmental regulation of metastasis | Q29547660 | ||
| The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies | Q29614311 | ||
| Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy | Q29614312 | ||
| CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis | Q29614347 | ||
| Macrophage diversity enhances tumor progression and metastasis | Q29615847 | ||
| Accessories to the crime: functions of cells recruited to the tumor microenvironment | Q29620161 | ||
| Stromal gene expression predicts clinical outcome in breast cancer | Q33330931 | ||
| CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization | Q33553562 | ||
| Inflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism | Q33927221 | ||
| Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model. | Q34059489 | ||
| Monocyte-mediated defense against microbial pathogens. | Q34065898 | ||
| Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases | Q34272277 | ||
| A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors. | Q34326476 | ||
| The cellular and molecular origin of tumor-associated macrophages | Q34378833 | ||
| Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy | Q34744555 | ||
| Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. | Q35800693 | ||
| CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease | Q36177928 | ||
| Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line | Q36356054 | ||
| A key role for CC chemokine receptor 1 in T-cell-mediated respiratory inflammation | Q36559678 | ||
| Macrophages and the hypoxic tumour microenvironment | Q36813993 | ||
| Trophic macrophages in development and disease | Q36829147 | ||
| Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice. | Q36879234 | ||
| High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors | Q37150829 | ||
| Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone | Q37431256 | ||
| Alveolar macrophages: plasticity in a tissue-specific context | Q38180346 | ||
| CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process | Q39926718 | ||
| Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in mice | Q39958799 | ||
| Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior | Q40379730 | ||
| MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. | Q40454635 | ||
| Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials | Q40903938 | ||
| Identification of molecular apocrine breast tumours by microarray analysis. | Q42478400 | ||
| Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma. | Q42803679 | ||
| Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial | Q43696394 | ||
| M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication. | Q43837736 | ||
| Pharmacokinetic and pharmacodynamic evaluation of the novel CCR1 antagonist CCX354 in healthy human subjects: implications for selection of clinical dose. | Q45999111 | ||
| Overcoming hurdles in developing successful drugs targeting chemokine receptors | Q46441158 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| macrophage | Q184204 | ||
| cancer metastasis | Q120912394 | ||
| P304 | page(s) | 1043-1059 | |
| P577 | publication date | 2015-06-08 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages | |
| P478 | volume | 212 |
| Q90176023 | A Fluorescent Activatable AND-Gate Chemokine CCL2 Enables In Vivo Detection of Metastasis-Associated Macrophages |
| Q37708858 | A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo |
| Q88488558 | A history of exploring cancer in context |
| Q38672995 | AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients |
| Q91903913 | Acute and chronic hypoxia differentially predispose lungs for metastases |
| Q33602761 | Apigenin inhibits TNFα/IL-1α-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells |
| Q38557650 | Applying nanomedicine in maladaptive inflammation and angiogenesis |
| Q37197605 | Benzopyrene promotes lung cancer A549 cell migration and invasion through up-regulating cytokine IL8 and chemokines CCL2 and CCL3 expression |
| Q53099163 | Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages. |
| Q38752744 | Biomaterials approaches to modeling macrophage-extracellular matrix interactions in the tumor microenvironment |
| Q39443694 | Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack |
| Q40619963 | CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells |
| Q97645032 | CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo |
| Q89906004 | CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis |
| Q64063427 | CCL2/CCR2 Axis Promotes the Progression of Salivary Adenoid Cystic Carcinoma via Recruiting and Reprogramming the Tumor-Associated Macrophages |
| Q36184349 | CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice |
| Q89724951 | CCL3 Signaling in the Tumor Microenvironment |
| Q93183891 | CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation |
| Q92000046 | CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer |
| Q55381087 | CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis. |
| Q37728730 | CXCR3+ monocytes/macrophages are required for establishment of pulmonary metastases |
| Q90023404 | Cancer Cells and M2 Macrophages: Cooperative Invasive Ecosystem Engineers |
| Q54218762 | Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints. |
| Q88688308 | Cancer Inflammation and Cytokines |
| Q90207575 | Cancer associated fibroblast FAK regulates malignant cell metabolism |
| Q36751625 | Cancer immunosurveillance: role of patrolling monocytes |
| Q55122201 | Cancer stem cells as key drivers of tumour progression. |
| Q37317505 | Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis |
| Q57492017 | Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity |
| Q58758969 | Chemokine-Induced Macrophage Polarization in Inflammatory Conditions |
| Q64094870 | Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy |
| Q60931267 | Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization |
| Q93001507 | Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers |
| Q47719808 | Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3. |
| Q39337489 | Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy |
| Q90833182 | Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models |
| Q92734021 | Chemotherapy-Induced Metastasis: Molecular Mechanisms, Clinical Manifestations, Therapeutic Interventions |
| Q36454593 | Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells |
| Q48290538 | Clinical evaluation of macrophages in cancer: role in treatment, modulation and challenges. |
| Q90087580 | Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer |
| Q40060254 | Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes. |
| Q55403730 | Digital gene expression profiling analysis and its application in the identification of genes associated with improved response to neoadjuvant chemotherapy in breast cancer. |
| Q88963825 | Distant Relations: Macrophage Functions in the Metastatic Niche |
| Q55153696 | Distinct alterations of CD68+CD163+ M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment. |
| Q58740344 | Drug resistance and new therapies in colorectal cancer |
| Q90292633 | Elevated Expression Levels of PC3-Secreted Microprotein (PSMP) in Prostate Cancer Associated With Increased Xenograft Growth and Modification of Immune-Related Microenvironment |
| Q103826247 | Emerging immunotherapies for metastasis |
| Q96128419 | Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration |
| Q90278401 | Eotaxin‑1 and MCP‑1 serve as circulating indicators in response to power frequency electromagnetic field exposure in mice |
| Q49188109 | Equal Pro-inflammatory Profiles of CCLs, CXCLs, and Matrix Metalloproteinases in the Extracellular Microenvironment In Vivo in Human Dense Breast Tissue and Breast Cancer |
| Q47141962 | Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration |
| Q35992191 | FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis |
| Q55024893 | Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking. |
| Q34482849 | Fatal attraction: How macrophages participate in tumor metastases |
| Q52714523 | Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. |
| Q47956086 | GK-1 peptide reduces tumor growth, decreases metastatic burden, and increases survival in a murine breast cancer model |
| Q60046564 | Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis |
| Q57106917 | Genetics and biology of prostate cancer |
| Q37599077 | Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis |
| Q39270453 | Harnessing antitumor immunity: Employment of tumor recall antigens to optimize the inflammatory response to cancer |
| Q58112391 | High expression of CCL2 in tumor cells and abundant infiltration with CD14 positive macrophages predict early relapse in breast cancer |
| Q55112573 | Host chemokine signature as a biomarker for the detection of pre-cancerous cervical lesions. |
| Q64112523 | Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets |
| Q39144794 | Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity |
| Q90312211 | Identification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray Data |
| Q92572055 | Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy |
| Q48507775 | Imaging macrophage distribution and density in mammary tumors and lung metastases using fluorine-19 MRI cell tracking |
| Q37719488 | Immune Regulation of the Metastatic Process: Implications for Therapy |
| Q89556686 | Immune crosstalk in cancer progression and metastatic spread: a complex conversation |
| Q90573717 | Immune effector monocyte-neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer |
| Q53743967 | Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies. |
| Q94452370 | Immunomodulation by anticancer cell cycle inhibitors |
| Q92811129 | Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges |
| Q46511830 | Immunosurveillance and immunoediting in MMTV-PyMT-induced mammary oncogenesis |
| Q27310991 | In vivo subcellular resolution optical imaging in the lung reveals early metastatic proliferation and motility |
| Q37619697 | Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer |
| Q40399998 | Induction of the MCP chemokine cluster cascade in the periphery by cancer cell-derived Ccl3. |
| Q47739102 | Inflammatory Monocytes Promote Perineural Invasion via CCL2-Mediated Recruitment and Cathepsin B Expression |
| Q64929428 | Influence of Resveratrol on the Immune Response. |
| Q64269743 | Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer |
| Q59799266 | KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production |
| Q30827238 | Long-term High-Resolution Intravital Microscopy in the Lung with a Vacuum Stabilized Imaging Window |
| Q92577677 | Low infiltration of tumor-associated macrophages in high c-Myb-expressing breast tumors |
| Q60926258 | Lung Macrophages: Multifunctional Regulator Cells for Metastatic Cells |
| Q64071901 | Macrophage Origin, Metabolic Reprogramming and IL-1 Signaling: Promises and Pitfalls in Lung Cancer |
| Q64453681 | Macrophage targeting: opening new possibilities for cancer immunotherapy |
| Q36972901 | Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis. |
| Q37624909 | Macrophages as Key Drivers of Cancer Progression and Metastasis. |
| Q91856351 | Macrophages in Colorectal Cancer Liver Metastases |
| Q64967887 | Macrophages of distinct origins contribute to tumor development in the lung. |
| Q47217923 | Macrophages orchestrate breast cancer early dissemination and metastasis. |
| Q26765377 | Macrophages: Regulators of the Inflammatory Microenvironment during Mammary Gland Development and Breast Cancer |
| Q52321369 | Macrophages: The Road Less Traveled, Changing Anticancer Therapy. |
| Q90729543 | Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF |
| Q41338881 | Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages. |
| Q47137850 | Manipulation of Innate Immunity for Cancer Therapy in Dogs. |
| Q91769001 | Mechanisms of immune evasion in bladder cancer |
| Q50117508 | MiRNAs at the Crossroads between Innate Immunity and Cancer: Focus on Macrophages |
| Q38936695 | Microenvironmental Effects of Cell Death in Malignant Disease. |
| Q90212845 | Microporous scaffolds loaded with immunomodulatory lentivirus to study the contribution of immune cell populations to tumor cell recruitment in vivo |
| Q33736438 | Molecular Signatures of Human Regulatory T Cells in Colorectal Cancer and Polyps |
| Q49539665 | Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer |
| Q46758501 | Myc Cooperates with Ras by Programming Inflammation and Immune Suppression |
| Q89976160 | Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer |
| Q36895360 | Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment. |
| Q28072045 | New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy |
| Q50249667 | Nonresolving macrophage-mediated inflammation in malignancy |
| Q37330542 | Obesity-associated NLRC4 inflammasome activation drives breast cancer progression |
| Q99608447 | Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1 |
| Q33902543 | On-chip human microvasculature assay for visualization and quantification of tumor cell extravasation dynamics |
| Q39011826 | One microenvironment does not fit all: heterogeneity beyond cancer cells |
| Q36265801 | Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells |
| Q92638951 | PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway |
| Q28080046 | Patient-derived tumour xenografts for breast cancer drug discovery |
| Q47437633 | Phagocyte-extracellular matrix crosstalk empowers tumor development and dissemination |
| Q91015172 | Prognostic significance and population dynamics of peripheral monocytes in patients with oropharyngeal squamous cell carcinoma |
| Q64998025 | Proteolytic and Opportunistic Breaching of the Basement Membrane Zone by Immune Cells during Tumor Initiation. |
| Q91774972 | Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology |
| Q41011622 | Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies |
| Q52628012 | Role of Macrophages in Brain Tumor Growth and Progression. |
| Q48957796 | Role of monocyte recruitment in hemangiosarcoma metastasis in dogs. |
| Q38904869 | Role of tumor-associated macrophages in human malignancies: friend or foe? |
| Q90467790 | S100 Soil Sensor Receptors and Molecular Targeting Therapy Against Them in Cancer Metastasis |
| Q90444207 | SARI suppresses colitis-associated cancer development by maintaining MCP-1-mediated tumour-associated macrophage recruitment |
| Q47100529 | Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET. |
| Q55235442 | Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer. |
| Q88714622 | Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis |
| Q91981643 | Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity |
| Q45226905 | Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth |
| Q55518188 | Synergy between peroxisome proliferator-activated receptor γ agonist and radiotherapy in cancer. |
| Q59329292 | Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors |
| Q55315292 | Targeting Macrophages in Cancer: From Bench to Bedside. |
| Q58547311 | Targeting macrophages: therapeutic approaches in cancer |
| Q38786658 | Targeting metastasis |
| Q26765184 | Targeting the CCL2-CCR2 signaling axis in cancer metastasis |
| Q64105357 | The Contribution of the Immune System in Bone Metastasis Pathogenesis |
| Q39188002 | The Dr. Jekyll and Mr. Hyde complexity of the macrophage response in disease |
| Q89847373 | The G protein coupled receptor CCR5 in cancer |
| Q97521683 | The Impact of the Cancer Microenvironment on Macrophage Phenotypes |
| Q57166654 | The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy |
| Q38895474 | The Multifaceted Role of Perivascular Macrophages in Tumors |
| Q28388630 | The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment |
| Q38950549 | The Relationship Between Dormant Cancer Cells and Their Microenvironment |
| Q26748194 | The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis |
| Q39346175 | The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress |
| Q36265616 | The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo |
| Q42155981 | The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. |
| Q52726107 | The effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model. |
| Q102388833 | The fibrotic and immune microenvironments as targetable drivers of metastasis |
| Q41073699 | The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis |
| Q38896944 | The hypoxic microenvironment: A determinant of cancer stem cell evolution |
| Q33660069 | The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy. |
| Q48218215 | The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation. |
| Q89507027 | The metabolic axis of macrophage and immune cell polarization |
| Q38875474 | The role of myeloid cells in cancer therapies |
| Q26798116 | Therapeutic potential of chemokine signal inhibition for metastatic breast cancer |
| Q83600797 | Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant |
| Q47398521 | Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding. |
| Q49544289 | Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer |
| Q50104130 | Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies |
| Q40103834 | Tumor location determines tissue-specific recruitment of tumor-associated macrophages and antibody-dependent immunotherapy response. |
| Q64118797 | Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer |
| Q54967714 | Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy. |
| Q36692838 | Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. |
| Q39100693 | Tumour-associated macrophages as treatment targets in oncology. |
| Q52311744 | Understanding the tumor immune microenvironment (TIME) for effective therapy. |
| Q89260318 | Urine biomarkers in renal allograft |
| Q97435733 | Using Cytometry for Investigation of Purinergic Signaling in Tumor-Associated Macrophages |
| Q37224595 | Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma. |
| Q47727746 | What DKKtates where to metastasize |
| Q41858851 | Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma. |
Search more.